scholarly article | Q13442814 |
P50 | author | Graciela S Alarcón | Q67485107 |
John D Reveille | Q67485113 | ||
P2093 | author name string | G McGwin | |
L M Vilá | |||
B J Fessler | |||
M Fernández | |||
H M Bastian | |||
L B Tucker | |||
M Apte | |||
A G Uribe | |||
P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus | Q33205432 | ||
Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage | Q33341018 | ||
What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading? | Q34332377 | ||
Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults | Q35548094 | ||
Socioeconomic factors in lupus erythematosus | Q36127521 | ||
Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently | Q36567813 | ||
The clinical spectrum of systemic lupus erythematosus in childhood | Q40471208 | ||
Learned helplessness in systemic lupus erythematosus: analysis using the Rheumatology Attitudes Index | Q43454995 | ||
Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage | Q43464309 | ||
Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome | Q46262236 | ||
Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture | Q46430510 | ||
Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus. | Q46492185 | ||
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus | Q57740770 | ||
Transition of the Adolescent Patient with Rheumatic Disease: Issues to Consider | Q60998453 | ||
Systemic lupus erythematosus in a multiethnic US cohort: Clinical features, course, and outcome in patients with late-onset disease | Q61811922 | ||
Morbidity associated with childhood systemic lupus erythematosus | Q68560389 | ||
Dimensions of illness behaviour as measured by the Illness Behaviour Questionnaire: a replication study | Q70531938 | ||
Unfavorable outcomes (end-stage renal failure/death) in childhood onset systemic lupus erythematosus. A multicenter study in Paris and its environs | Q72792901 | ||
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus | Q73343774 | ||
Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study | Q73792263 | ||
Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture | Q74776728 | ||
Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity | Q75828790 | ||
Mortality patterns in childhood lupus--10 years' experience in a developing country | Q78560061 | ||
A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus | Q80201696 | ||
P433 | issue | 4 | |
P921 | main subject | teenager | Q1492760 |
multiethnicity | Q111242702 | ||
P304 | page(s) | 314-322 | |
P577 | publication date | 2008-04-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII) | |
P478 | volume | 17 |
Q37845009 | Acute pancreatitis in pediatric and adult-onset systemic lupus erythematosus: a comparison and review of the literature |
Q38048234 | Adding to complexity: comorbidity in paediatric rheumatic disease. |
Q27690838 | Adult outcomes of childhood-onset rheumatic diseases |
Q40299868 | Age-related differences in the clinical characteristics of systemic lupus erythematosus in children |
Q48361761 | Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus. |
Q34498858 | Association of health-related quality of life in childhood-onset systemic lupus erythematosus with ethnicity: results from a multiethnic multicenter Canadian cohort |
Q36375184 | Association of miRNA-145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis |
Q26785472 | Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus |
Q35825371 | Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus |
Q28082493 | Biomarkers for CNS involvement in pediatric lupus |
Q57467570 | Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease |
Q38223293 | Childhood onset systemic lupus erythematosus: how is it different from adult SLE? |
Q39067278 | Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality. |
Q37754678 | Childhood- and adult-onset lupus: an update of similarities and differences. |
Q37127464 | Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus |
Q40995930 | Childhood-onset systemic lupus erythematosus in Singapore: clinical phenotypes, disease activity, damage, and autoantibody profiles |
Q51196776 | Children and adolescents with SLE: not just little adults. |
Q33755568 | Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry IX: Clinical Features and Survival of Childhood-Onset Systemic Lupus Erythematosus in China |
Q86015625 | Clinical applications of the indirect immunofluorescence assay for detection of anticell membrane-associated DNA antibodies in juvenile systemic lupus erythematosus |
Q31058821 | Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register. |
Q42019937 | Clinical features and mortality in Chinese with lupus nephritis and neuropsychiatric lupus: A 124-patient study |
Q34146671 | Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. |
Q40112299 | Cognitive Function in Children with Lupus Nephritis: A Cross-Sectional Comparison with Children with Other Glomerular Chronic Kidney Diseases |
Q38969469 | Comparative effectiveness of mycophenolate mofetil for the treatment of childhood-onset proliferative lupus nephritis |
Q33423725 | Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients. |
Q38922218 | Contraception for adolescents with chronic rheumatic diseases |
Q58746511 | Dietary Docosahexaenoic Acid Prevents Silica-Induced Development of Pulmonary Ectopic Germinal Centers and Glomerulonephritis in the Lupus-Prone NZBWF1 Mouse |
Q40038921 | Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: A systematic review and meta-analysis |
Q33397369 | Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis |
Q33431990 | Differences in disease phenotype and severity in SLE across age groups |
Q33871944 | Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus |
Q102075384 | Differential parameters between activity flare and acute infection in pediatric patients with systemic lupus erythematosus |
Q45812853 | Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort |
Q24234659 | Disease modifying immunosuppressant drugs for juvenile-onset systemic lupus erythematosus |
Q98578405 | Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach |
Q34554770 | Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients |
Q33725656 | Educational and vocational outcomes of adults with childhood- and adult-onset systemic lupus erythematosus: nine years of followup |
Q43816395 | Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement |
Q35082426 | End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. |
Q37778652 | Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus |
Q53839415 | Epidemiology of systemic lupus erythematosus. |
Q90621316 | Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies? |
Q43752384 | European ancestry decreases the risk of early onset, severe lupus nephritis in a single center, multiethnic pediatric lupus inception cohort |
Q48617296 | Evaluation of cardiac functions in juvenile systemic lupus erythematosus with two-dimensional speckle tracking echocardiography. |
Q38865389 | Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis |
Q55112474 | Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis. |
Q39001634 | From Childhood to Adulthood: The Trajectory of Damage in Patients with Childhood-Onset Systemic Lupus Erythematosus |
Q47383976 | High Health Care Utilization Preceding Diagnosis of Systemic Lupus Erythematosus in Youth. |
Q35614906 | How does age at onset influence the outcome of autoimmune diseases? |
Q37342980 | Hypogammaglobulinemia in pediatric systemic lupus erythematosus |
Q52670887 | Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis. |
Q48911979 | Impact of lupus on school attendance and performance |
Q58795695 | Improvement of survival rates in the last decade in Thai childhood-onset systemic lupus erythematosus |
Q40209873 | Increased Incidence of juvenile onset systemic lupus erythematosus in children with atopic dermatitis. |
Q36313012 | Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort |
Q37256607 | Inpatient health care utilization by children and adolescents with systemic lupus erythematosus and kidney involvement |
Q38877052 | Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective |
Q48654210 | Inter-observer variability of the histological classification of lupus glomerulonephritis in children |
Q37547407 | International validation of a urinary biomarker panel for identification of active lupus nephritis in children |
Q44593708 | Juvenile and adult-onset systemic lupus erythematosus: an ethnicity-based comparison. |
Q36702788 | Juvenile systemic lupus erythematosus with primary neuropsychiatric presentation |
Q26849746 | Juvenile systemic lupus erythematosus: review of clinical features and management |
Q39282087 | Lupus Means Sacrifices: Perspectives of Adolescents and Young Adults With Systemic Lupus Erythematosus. |
Q96952828 | Management of Pediatric Systemic Lupus Erythematosus: Focus on Belimumab |
Q53064991 | Mean platelet volume as an indicator of disease activity in juvenile SLE. |
Q39017776 | Moyamoya and Inflammation |
Q52839936 | Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients. |
Q34307491 | Neurocognitive deficits and neuroimaging abnormalities are prevalent in children with lupus: clinical and research experiences at a US pediatric institution |
Q34310715 | Neurologic manifestations of systemic lupus erythematosus in children and adults |
Q40242117 | Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years. |
Q84561164 | Paediatric rheumatic disease: lessons from SLE: children are not little adults |
Q37850999 | Pediatric SLE--towards a comprehensive management plan |
Q55387947 | Pediatric Systemic Lupus Erythematosus: Learning From Longer Follow Up to Adulthood. |
Q33723511 | Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? |
Q38771936 | Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus |
Q37738685 | Pitfalls and opportunities in measuring patient outcomes in lupus |
Q36903365 | Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus |
Q84594208 | Predictors for neuropsychiatric development in Chinese adolescents with systemic lupus erythematosus |
Q47292875 | Predictors of disability in a childhood-onset systemic lupus erythematosus cohort: results from the CARRA Legacy Registry |
Q47807744 | Pregnancy outcomes in women with childhood-onset and adult-onset systemic lupus erythematosus: a comparative study |
Q37777642 | Prevalence and burden of pediatric-onset systemic lupus erythematosus |
Q36587996 | Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population |
Q40228639 | Profile of paediatric rheumatology specialists and services in the state of São Paulo. |
Q36759019 | Prolidase deficiency associated with systemic lupus erythematosus (SLE): single site experience and literature review |
Q41962710 | Psychotic Symptoms in a Child with Long Standing SLE Nephritis: Neuropsychiatric Manifestation or Sequelae to Lupus? |
Q58755522 | Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study |
Q33387223 | SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study. |
Q37272264 | Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices |
Q40041622 | Sex Differences in Pediatric Rheumatology. |
Q41680587 | Similarities and differences between pediatric and adult patients with systemic lupus erythematosus |
Q88551313 | Spectrum of systemic lupus erythematosus in Oman: from childhood to adulthood |
Q41435721 | Subclinical left ventricular dysfunction in childhood-onset systemic lupus erythematosus: a two-dimensional speckle-tracking echocardiographic study |
Q55282858 | Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner. |
Q35947491 | Systemic lupus erythematosus in children and adolescents |
Q36295937 | Taxonomy for systemic lupus erythematosus with onset before adulthood |
Q94570836 | The Comparison of Nailfold Capillaroscopy between Juvenile Systemic Lupus Erythematosus and Healthy Controls: Correlation with Laboratory and Clinical Parameters |
Q38804154 | The association between initial manifestations of childhood-onset systemic lupus erythematosus and the survival |
Q44723933 | The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort. |
Q51121176 | The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE. |
Q40224772 | The prevalence of systemic autoimmune rheumatic diseases in Canadian pediatric populations: administrative database estimates |
Q58785147 | Transition and transfer of the patient with paediatric-onset lupus: a practical approach for paediatric and adult rheumatology practices |
Q40978743 | Transition of Care and Health-Related Outcomes in Pediatric-Onset Systemic Lupus Erythematosus |
Q37690103 | Update on differences between childhood-onset and adult-onset systemic lupus erythematosus |
Q33818710 | Use of atorvastatin in systemic lupus erythematosus in children and adolescents |
Q38011226 | Utilizing registries in systemic lupus erythematosus clinical research |
Q89030349 | [Connective tissue diseases in adolescents] |
Search more.